Apex, NC, United States of America

Thomas Davis Roper, Iv


Average Co-Inventor Count = 8.9

ph-index = 2

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Thomas Davis Roper, IV: Exploring His Patents and Collaborations

Introduction: Thomas Davis Roper, IV, a notable inventor based in Apex, North Carolina, has made significant contributions to the field of medicine through his innovative patents. With two patents to his name, Roper focuses on developing new compounds that address inflammatory diseases, showcasing his expertise and dedication to improving healthcare.

Latest Patents: Roper's latest patents revolve around a series of compounds known as 2-(Purin-9-yl)-tetrahydrofuran-3,4-diol derivatives. These compounds exhibit broad anti-inflammatory properties, effectively inhibiting leukocyte recruitment and activation while acting as agonists of the adenosine 2 receptor. Moreover, his patented work includes processes for preparing these novel compounds, as well as formulations that are aimed at therapeutic applications for treating various inflammatory diseases.

Career Highlights: Thomas Roper's career is marked by his innovative approach to drug development at SmithKline Beecham Corporation. His work on therapeutic compounds demonstrates not only his scientific acumen but also his commitment to contributing to medical advancements. Through his research and patented inventions, Roper seeks to provide new solutions for unmet medical needs in the area of inflammation.

Collaborations: Throughout his career, Roper has had the privilege of collaborating with esteemed colleagues such as Brian Cox and Suzanne Elaine Keeling. These collaborations have likely enriched his research and innovation efforts, fostering an environment of creativity and scientific exploration at SmithKline Beecham Corporation.

Conclusion: Thomas Davis Roper, IV is an exemplary figure in the field of innovation, with a focus on the development of impactful therapeutic compounds. His work on 2-(Purin-9-yl)-tetrahydrofuran-3,4-diol derivatives highlights the potential for new treatments in the fight against inflammatory diseases. Through collaborations and a commitment to excellence, Roper continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…